Ascentia Biomedical Corporation Announces A Shift To Biomedical Arbitrage And Development To Achieve Profitability
5/30/2006 11:46:40 AM
More...
|
Ascentia Biomedical Corporation Announces The Addition Of Dr. Philip Mease, An Internationally Recognized Rheumatologist, To The Scientific Advisory Board
10/19/2005 5:13:08 PM
More...
|
Ascentia Biomedical Corporation Announces Its High Profile Scientific Advisory Board
10/19/2005 5:09:25 PM
More...
|
Ascentia Biomedical Corporation Receives $1 Million Funding Commitment To Support Continued Research And Organizational Growth
10/19/2005 5:09:20 PM
More...
|
Ascentia Biomedical Corporation Further Defines Option Agreement With University of Washington For Anti-Cancer Compound
10/19/2005 5:09:11 PM
More...
|
Ascentia Biomedical Corporation Announces Option Agreement With University of Washington For Anti-Cancer Compound
10/19/2005 5:09:08 PM
More...
|
Ascentia Biomedical Corporation Announces New Laboratory And Office Space; Adds Dr. Peter Klein, Renown Pharmaceutical Chemist To Its Staff
10/19/2005 5:09:00 PM
More...
|